BCRX vs PPL · rev $374.7M vs P/E 22, rev $9.04B
BioCryst Pharmaceuticals Inc (BCRX) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Latest reported BCRX revenue for 2026-06-30 was $374.7M. Net income was -$643.4M. BCRX currently screens at market cap $1.83B.
Latest reported PPL revenue for 2025-12-31 was $9.04B. Net income was $1.18B. Revenue was up 6.9% from 2024-12-31 to 2025-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
BCRX currently screens at market cap $1.83B. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the BCRX and PPL stock pages for the full models.
Not investment advice.